Diabetes

Edit Answers
12345678910111213141516171819202122232425262728293031323334353637383940414243
Across
  1. 1. Route of administration of meglitinide analogs, metformin, alpha-glucosidase inhibitors, TZDs, DPP-4 inhibitors...
  2. 5. Focal ischemia / Manifestation such as: pain, asymmetric weakness; wasting of iliopsoas, quadriceps, and adductor muscles
  3. 9. abbreviation of a hyperglycemia state caused by hyperglycemia
  4. 10. plasma glucose test that is used for nonpregnant adults; patient requires to stop eating 8 hours before test ( Test needs to be done twice of value > 126 mg/dL to be dx as DM)
  5. 11. Initial antidiabetic therapy that's recommended to DM type 2; is a type of insulin sensitizers
  6. 13. Route of administration of Increatin mimetics and amylin
  7. 15. Delay in gastric emptying - one of the cause of hypoglycemia
  8. 19. Often is the first indicator of chronic graft injection; presence of protein in urine
  9. 22. ... maneuver; teach patient with retinopathy to avoid this maneuver because it increases blood pressure ---> causing vitreuos hemorrhage
  10. 24. Increased fat deposits in the skin, often caused by not rotating insulin injection site
  11. 27. the most common precipitating factor for development of DKA
  12. 28. Insulin secretagogue agent that stimulates insulin release; second-generation agents are often used
  13. 29. microvascular complication leading to kidney dysfunction
  14. 32. Short-acting antidiabetic med that increases insulin secretion
  15. 33. amount of time ( in minutes) insulin Lispro,or Aspart should be given before meal-time (spell number out)
  16. 34. This long-acting type of insulin should NOT be mixed with any other forms of insulin
  17. 35. Basal insulin coverage is often provided by this type of insulin
  18. 36. microvascular complication leading to nerve dysfunction
  19. 37. Condition that's defined as having IFG of 100-125 mg/dL, and IGT of 140-199mg/dL
  20. 40. Neuropathy type that affects a single nerve or nerve entrapment
  21. 41. abbreviation of a diabetic condition that is characterized by uncontrolled hyperglycemia, metabolic acidosis, and increased production of ketones. This condition results from the combination of insulin deficiency and an increase in counterregulatory hormones.
  22. 43. A drug in the alpha-glucosidase inhibitors class
Down
  1. 2. The fastest absorption site of insulin injection
  2. 3. Excessive eating
  3. 4. main counterregulatory hormone; overtime type1 DM patients' pancreas lose the ability to make this hormone in response to hypoglycemia
  4. 6. Type of respiration r/t metabolic acidosis
  5. 7. Type of neuropathy that involve widespread nerve function ( the most common neuropathy in DM patient)
  6. 8. a type of insulin sensitizers that increases cellular utilization of glucose; side effects are increase in adipose tissue, fluid retention and weight gain
  7. 12. this type of symptoms result from autonomic nervous activity triggered by a rapid decline in blood glucose; such as: shaky/ tremulous, heart pounding, sweaty, hungry, tingling
  8. 14. this type of symptoms occur when brain glucose gradually declines to a low level; such as: weakness, difficulty thinking, confusion, seizures, loss of consciousness
  9. 16. microvascular complication leading to vision problem
  10. 17. Increased protein or nitrogen waste products in the blood
  11. 18. age-related farsightedness, often made worse by burred vision caused by fluctuating blood glucose
  12. 20. Burning, stinging, or stabbing pain / Sensory alteration / Distal symmetric polyneuropathy
  13. 21. Test that reflects the amount of glucose binding to serum protein; is helpful in indicating tight control of blood glucose
  14. 23. Presence of albumin in urine, indication of kidney damage
  15. 25. Burning, tingling sensation that starts out in toes and moves up the extremities ( Sensory alterations / Distal symmetric polynneuropathies)
  16. 26. common type of electrolyte imbalances, often seen in patients with mild to moderate kidney failure
  17. 30. Excessive thirst
  18. 31. a test that measures how much glucose permanently attaches to a specific area of hemoglobin
  19. 37. Frequent and excessive urination
  20. 38. Phenomenon of blood glucose elevation at around 5-6AM caused by nigh time release of growth hormone
  21. 39. Phenomenon of morning hyperglycemia from the counterregulatory response to nighttime hypoglycemia
  22. 42. when this substance is present in urine, DM patient should not exercise